Dianthus Therapeutics, Inc.
DNTH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001690585
In the last 90 days, Dianthus Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 269 institutions reported holding it in 13F filings for Q2 2026, worth $6.40B in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Dianthus Therapeutics, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 166
- +29 vs. Q3 2025
- Shares held
- 49.1M
- +2.30M (+4.9%) vs. Q3 2025
- Total value
- $2.02B
- +$182.0M (+9.9%) vs. Q3 2025
- New holders
- 47
- 75 more added
- Sold out
- 18
- 27 more reduced
3 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DNTH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 269 | $6.40B |
| Q1 2026 | 241 | $5.18B |
| Q4 2025 | 166 | $2.02B |
| Q3 2025 | 140 | $1.84B |
| Q2 2025 | 103 | $728.6M |
| Q1 2025 | 99 | $685.5M |
| Q4 2024 | 96 | $765.7M |
| Q3 2024 | 91 | $858.7M |
| Q2 2024 | 74 | $768.8M |
| Q1 2024 | 76 | $782.3M |
| Q4 2023 | 39 | $106.5M |
| Q3 2023 | 30 | $136.3M |
| Q2 2023 | 46 | $22.0M |
| Q1 2023 | 52 | $23.6M |
| Q4 2022 | 54 | $11.1M |
| Q3 2022 | 72 | $65.8M |
| Q2 2022 | 75 | $54.6M |
| Q1 2022 | 93 | $138.9M |
| Q4 2021 | 94 | $211.4M |
| Q3 2021 | 93 | $276.0M |
| Q2 2021 | 97 | $366.3M |
| Q1 2021 | 90 | $418.4M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Dianthus Therapeutics, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Neuberger Berman Group LLC | 87,782 | $3.62M | 0.00% | +87,782 | New |
| SummitTX Capital, L.P. | 87,926 | $3.62M | 0.11% | +87,926 | New |
| Russell Investments Group, Ltd. | 88,289 | $3.64M | 0.00% | +86,671+5,356.7% | Added |
| Rhenman & Partners Asset Management AB | 98,627 | $4.06M | 0.38% | −75,000−43.2% | Reduced |
| PFM Health Sciences, LP | 99,576 | $4.10M | 0.42% | +31,736+46.8% | Added |
| Invesco Ltd. | 101,489 | $4.18M | 0.00% | +56,560+125.9% | Added |
| Affinity Asset Advisors, LLC | 115,000 | $4.74M | 0.34% | −147,100−56.1% | Reduced |
| Algert Global LLC | 130,326 | $5.37M | 0.08% | +130,326 | New |
| Ensign Peak Advisors, Inc | 134,416 | $5.54M | 0.01% | 00.0% | Unchanged |
| Atika Capital Management LLC | 134,528 | $5.54M | 0.77% | +134,528 | New |
| Patient Square Capital LP | 150,000 | $6.18M | 1.32% | +25,000+20.0% | Added |
| D. E. Shaw & Co., Inc. | 154,678 | $6.37M | 0.00% | +123,064+389.3% | Added |
| Ameriprise Financial Inc | 155,163 | $6.39M | 0.00% | +51,408+49.5% | Added |
| Barclays PLC | 176,300 | $7.27M | 0.00% | −28,069−13.7% | Reduced |
| Atom Investors LP | 181,860 | $7.49M | 0.60% | +120,822+197.9% | Added |
| Schonfeld Strategic Advisors LLC | 182,619 | $7.53M | 0.04% | +54,366+42.4% | Added |
| Nuveen, LLC | 190,615 | $7.86M | 0.00% | +147,374+340.8% | Added |
| Artia Global Partners LP | 205,090 | $8.45M | 1.36% | +96,367+88.6% | Added |
| Walleye Capital LLC | 205,815 | $8.48M | 0.05% | +64,686+45.8% | Added |
| Squarepoint Ops LLC | 207,119 | $8.54M | 0.02% | +207,119 | New |
| Northern Trust Corp | 207,246 | $8.54M | 0.00% | +49,715+31.6% | Added |
| Dimensional Fund Advisors LP | 210,673 | $8.68M | 0.00% | +201,984+2,324.6% | Added |
| Woodline Partners LP | 213,087 | $8.78M | 0.03% | +170,389+399.1% | Added |
| Morgan Stanley | 228,016 | $9.40M | 0.00% | +150,496+194.1% | Added |
| Iron Triangle Partners LP | 230,730 | $9.51M | 1.09% | +230,730 | New |
| ExodusPoint Capital Management, LP | 246,788 | $10.2M | 0.11% | +246,788 | New |
| Charles Schwab Investment Management Inc | 250,812 | $10.3M | 0.00% | +57,753+29.9% | Added |
| Tang Capital Management LLC | 264,692 | $10.9M | 0.54% | 00.0% | Unchanged |
| Integral Health Asset Management, LLC | 275,000 | $11.3M | 0.57% | +125,000+83.3% | Added |
| Spruce Street Capital LP | 297,437 | $12.3M | 4.05% | +297,437 | New |
| Candriam Luxembourg S.C.A. | 311,150 | $12.8M | 0.06% | +9,722+3.2% | Added |
| Logos Global Management LP | 315,000 | $13.0M | 0.87% | +115,000+57.5% | Added |
| Great Point Partners LLC | 350,000 | $14.4M | 4.68% | +84,197+31.7% | Added |
| Vivo Capital, LLC | 353,998 | $14.6M | 0.94% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 375,000 | $15.5M | 0.92% | 00.0% | Unchanged |
| Franklin Resources Inc | 462,826 | $19.1M | 0.00% | +12,515+2.8% | Added |
| Bank of America Corp | 465,538 | $19.2M | 0.00% | +285,513+158.6% | Added |
| Sio Capital Management, LLC | 474,503 | $19.6M | 3.24% | −103,247−17.9% | Reduced |
| BNP Paribas Arbitrage, SA | 475,749 | $19.6M | 0.01% | +441,156+1,275.3% | Added |
| Goldman Sachs Group Inc | 577,019 | $23.8M | 0.00% | +358,248+163.8% | Added |
| UBS Group AG | 606,620 | $25.0M | 0.00% | +469,547+342.6% | Added |
| Price T Rowe Associates Inc | 616,033 | $25.4M | 0.00% | +399,898+185.0% | Added |
| Tri Locum Partners LP | 622,403 | $25.6M | 3.33% | +439,536+240.4% | Added |
| Catalio Capital Management, LP | 653,572 | $26.9M | 4.76% | −14,043−2.1% | Reduced |
| Millennium Management LLC | 667,216 | $27.5M | 0.02% | +521,050+356.5% | Added |
| Geode Capital Management, LLC | 676,658 | $27.9M | 0.00% | +140,243+26.1% | Added |
| Bain Capital Life Sciences Investors, LLC | 743,592 | $30.6M | 2.35% | −572,300−43.5% | Reduced |
| Silverarc Capital Management, LLC | 750,136 | $30.9M | 4.47% | +75,170+11.1% | Added |
| Baker Bros. Advisors LP | 789,759 | $32.5M | 0.19% | 00.0% | Unchanged |
| Alliancebernstein L.P. | 834,383 | $34.4M | 0.01% | −18,001−2.1% | Reduced |
| VR Adviser, LLC | 1,000,000 | $41.2M | 2.04% | +39,197+4.1% | Added |
| Polar Capital Holdings Plc | 1,004,728 | $41.4M | 0.19% | +256,725+34.3% | Added |
| Marshall Wace, LLP | 1,008,533 | $41.6M | 0.04% | +435,595+76.0% | Added |
| Citadel Advisors LLC | 1,068,934 | $44.1M | 0.03% | +55,433+5.5% | Added |
| Point72 Asset Management, L.P. | 1,166,088 | $48.1M | 0.08% | −875,872−42.9% | Reduced |
| Braidwell LP | 1,273,935 | $52.5M | 1.68% | +438,878+52.6% | Added |
| State Street Corp | 1,507,619 | $62.1M | 0.00% | +836,571+124.7% | Added |
| Ra Capital Management, L.P. | 1,611,733 | $66.4M | 0.68% | −1,255,000−43.8% | Reduced |
| TCG Crossover Management, LLC | 1,676,624 | $69.1M | 2.29% | 00.0% | Unchanged |
| BlackRock, Inc. | 1,915,236 | $78.9M | 0.00% | +575,145+42.9% | Added |
| Vanguard Group Inc | 2,048,452 | $84.4M | 0.00% | +406,254+24.7% | Added |
| Avidity Partners Management LP | 2,104,184 | $86.7M | 25.01% | −1,100,000−34.3% | Reduced |
| Fairmount Funds Management LLC | 2,137,191 | $88.1M | 6.70% | −1,170,000−35.4% | Reduced |
| Octagon Capital Advisors LP | 2,416,667 | $99.6M | 12.47% | 00.0% | Unchanged |
| Wellington Management Group LLP | 2,503,190 | $103.2M | 0.02% | −74,472−2.9% | Reduced |
| FMR LLC | 6,431,329 | $265.0M | 0.01% | +460,691+7.7% | Added |
| Vestal Point Capital, LP | 0 | $0 | 0.00% | −1,180,000−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −443,703−100.0% | Sold out |
| 5AM Venture Management, LLC | 0 | $0 | 0.00% | −365,053−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −346,001−100.0% | Sold out |
| Alphabet Inc. | 0 | $0 | 0.00% | −208,697−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −138,963−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −138,561−100.0% | Sold out |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −77,000−100.0% | Sold out |
| Longaeva Partners L.P. | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −18,568−100.0% | Sold out |
| Quadrature Capital Ltd | 0 | $0 | 0.00% | −13,939−100.0% | Sold out |
| Omers Administration Corp | 0 | $0 | 0.00% | −12,100−100.0% | Sold out |
| Raymond James Financial Inc | 0 | $0 | 0.00% | −11,245−100.0% | Sold out |
| Ethic Inc. | 0 | $0 | 0.00% | −5,530−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −1,443−100.0% | Sold out |
| Crowley Wealth Management, Inc. | 0 | $0 | 0.00% | −221−100.0% | Sold out |
| Principal Securities, Inc. | 0 | $0 | 0.00% | −11−100.0% | Sold out |
| Montag A & Associates Inc | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| Glenmede Investment Management, LP | – | – | – | – | Not filed |
| Point72 Asia (Singapore) Pte. Ltd. | – | – | – | – | Not filed |
| Point72 (DIFC) Ltd | – | – | – | – | Not filed |